Stoke Therapeutics, Inc.
STOK
Revenue
4.83M
▲615.00k▲14.59%
3 Months ChangeAssets
307.76M
▲102.58M▲49.99%
3 Months ChangeLiabilities
65.05M
▲208.00k▲0.3208%
3 Months ChangeFree Cash Flow
-24.58M
▼-3.06M▼-14.20%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-10
Form 8-K
ID: 0001193125-24-216632
2024-08-07
Form 10-Q
ID: 0000950170-24-092738
2024-08-07
Form 8-K
ID: 0000950170-24-092268
2024-06-21
Form 8-K
ID: 0001193125-24-165651
2024-06-06
Form 8-K
ID: 0001193125-24-156049
2024-05-06
Form 10-Q
ID: 0000950170-24-053535
2024-05-06
Form 8-K
ID: 0000950170-24-053195
2024-04-29
Form 8-K
ID: 0001193125-24-122215
2024-03-28
Form 8-K
ID: 0001193125-24-080874
2024-03-25
Form 8-K
ID: 0001193125-24-076478